Fin & min. Hairloss/sheds/hair cycles
    Finasteride/Dutasteride 7/1/2025

    At a glance
    In this treatment experience post, the primary subjects mentioned are
    ๐Ÿ’Š Finasteride (oral) 1mg 6 months
    ๐Ÿ’ง Minoxidil (topical) 11 months
    the tone is ๐Ÿ˜ž negative with no improvement results.

    Other terms

    The user has been using finasteride and minoxidil for 11 months but is experiencing increased hair loss and no signs of improvement. Another user shares a similar experience and mentions iron deficiency and thyroid issues affecting hair loss despite using the treatments.
    View this post in the Community โ†’

    Similar Community Posts Join

    5 / 1000+ results

    Related Research

    6 / 1000+ results
      Hair Loss in Women

      research Hair Loss in Women

      129 citations , October 2007 in “The New England Journal of Medicine”
      Over one-third of women experience hair loss, with female-pattern hair loss being most common, and treatments include minoxidil and possibly hair transplantation.
      Telogen Effluvium: A Review of Acute and Chronic Forms

      research Telogen effluvium

      67 citations , January 2013 in “Indian Journal of Dermatology, Venereology and Leprology”
      Chronic Telogen Effluvium may resolve after years and is diagnosed by examining the patient's history and clinical signs, with treatment aimed at underlying causes and possibly minoxidil.
      Diseases of the Hair and Nails

      research Diseases of the Hair and Nails

      4 citations , November 2009 in “Medical Clinics of North America”
      Stress, nutritional issues, and chronic diseases can cause hair loss, and nail changes may signal internal diseases; treatment focuses on the underlying cause.
      Regional Dermatology: Hair and Nail Biology, Hair Loss Conditions, and Dermatological Issues of the Mouth and Genital Regions

      research Regional Dermatology

      1 citations , November 2014
      The document explains hair and nail biology, common hair loss conditions and treatments, oral and genital skin diseases, and the risks and treatments associated with squamous cell carcinoma.